FELIQS

Recent Finacing

Series A

Recent Raise

$9M

FELIQS is a Fukuoka-based biotech developing small-molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases; lead oral/IV candidate FLQ-101 aims to enhance retinal vascularization and prevent ROP.

Founded 2019

Fukuoka, Japan

1-10

Private

feliqs.com